Therapy for multiple myeloma - historical perspective: review of literature

  • strict warning: Non-static method view::load() should not be called statically in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/views.module on line 906.
  • strict warning: Declaration of views_handler_argument::init() should be compatible with views_handler::init(&$view, $options) in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/handlers/views_handler_argument.inc on line 744.
  • strict warning: Declaration of views_handler_filter::options_validate() should be compatible with views_handler::options_validate($form, &$form_state) in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/handlers/views_handler_filter.inc on line 607.
  • strict warning: Declaration of views_handler_filter::options_submit() should be compatible with views_handler::options_submit($form, &$form_state) in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/handlers/views_handler_filter.inc on line 607.
  • strict warning: Declaration of views_handler_filter_boolean_operator::value_validate() should be compatible with views_handler_filter::value_validate($form, &$form_state) in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/handlers/views_handler_filter_boolean_operator.inc on line 159.
  • strict warning: Non-static method view::load() should not be called statically in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/views.module on line 906.
  • strict warning: Non-static method view::load() should not be called statically in /home4/vibu/public_html/journalijdr.com/sites/all/modules/views/views.module on line 906.
Author: 
Dr. Lohit kumar Kalita, Dr. Pabitra Kamar Gogoi and Dr. Umesh Ch. Sarma
Abstract: 

The current therapeutic strategy for multiple myeloma has witnessed a dramatic improvement when compared with the rhubarb pill and infusion of orange peel that were used in 1844. It is still an incurable disease but the introduction of novel therapies have altered the natural course of the disease, transforming it into a chronic disease from a terminal illness. Recently an increased understanding of the interaction between the malignant plasma cells and the bone marrow microenvironment, cell-receptor ligand interactions and intracellular signalling pathways, have provided multiple opportunities to disrupt the development and progress of multiple myeloma. Following the success of thalidomide, lenalidomide, and bortezomib in multiple myeloma, a number of novel agents are currently investigation. These targeted therapies may enable personalization of therapy for individuals with myeloma in future.

Download PDF: 

CHIEF EDITOR

  

           Prof. Dr. Bilal BİLGİN

Call for Papers - 2017

    submit your paper now

   Vol. 07, Issue 03, March 2017

CURRENT ISSUE

 

Article Tracking

IMPACT FACTOR 2016

          4.753

Get your Certificate

Copyright © 2016 International Journal Development Research. All Rights Reserved.